The Firmwatch take
Caledonian Neuroscience Limited (SC246461) currently shows: No major warning signs in the latest extracted accounts, based on accounts to 30 April 2025; last refreshed 24 May 2026. No distress signals. Accounts cover the period ending 30 Apr 2025.
Companies House source·Accounts to 30 Apr 2025·Refreshed 24 May 2026·Methodology and caveats
Firmwatch signals are generated from public filings and are not credit ratings or financial advice.
Pulse · Net assets, 2024–2025
↗ £0Incorporated
26 March 2003
23 years on the register
Sector
Specialist medical practice
SIC 86220
Size
Not classified
Net assets
£100
Bottom 30% in sector
Cash at bank
Not disclosed
Not required for this filing type
Latest filing
None yet
Insolvency risk
Low insolvency risk
The latest public accounts do not show obvious balance-sheet stress. This does not rule out trading problems, but the filed numbers look comparatively steady.
Thin net asset buffer
The company reports a small visible net asset position.
Sector benchmark · Healthcare
How this company compares in 93,631 filers in this sector
Bottom 30% in sector — Caledonian Neuroscience Limited shows £100 in net assets. Sector median is £5k.
Sector medians are computed annually across all UK companies in this broad sector. Position is approximate — see the Money tab for the full balance sheet.
Money
What the balance sheet says
Net assets
£100
Bottom 30% in sector · sector median £5k · 93,631 filers in this sector
Cash
Not disclosed
Working cap.
£7k
Median £7k
Current ratio
2.4×
Median 1.8×
Signals · 1
Positive net assets
The latest filed accounts show assets exceeding liabilities.
People
Who runs this company
- ZS
ZUBERI, Sameer Mustafa, Professor
director · since 2003
Registered office
Address intelligence
2 other companies registered here.
Likely a privately owned office or residential address.
Firmwatch turns UK Companies House filings into plain-English company intelligence. Data is refreshed daily; signals are generated from public balance-sheet and filing patterns.